関連する実験動画
Updated: Jan 13, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.3K
中央およびアパラチアケンタッキー州における非ケトン性高グリシン血症
Shane Reeves1, Austin Wahle2, Larry B Goldstein3
1Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA.
Journal of child neurology
|January 6, 2026
まとめ
まれな遺伝性疾患である非ケトン性高グリシン血症(NKH)は、世界的な推定値よりもケンタッキー州で発生率が高い。この研究では、地域の遺伝子変異が特定されており、臨床医の認識向上と地域スクリーニング戦略の必要性が強調されている。
科学分野:
- 遺伝学
- 代謝性疾患
- 疫学
背景:
- 非ケトン性高グリシン血症(NKH)は、まれな遺伝性代謝性疾患です。
- 世界的な発生率は100,000人あたり0.4~1.3人の範囲であり、地域差があることが知られています。
研究 の 目的:
- 中央およびアパラチアケンタッキー州におけるNKHの地域出生時発生率を推定すること。
- この地域のNKH患者の臨床的および遺伝的特徴を記述すること。
主な方法:
- NKH診断基準を満たす患者の後ろ向きレビュー。
- 地域出生データを用いた出生時発生率の計算。
- 原因となる変異を特定するための患者の遺伝子解析。
主要な成果:
- 15人のNKH患者が特定され、そのうち13人はケンタッキー州生まれでした。
- この地域におけるNKHの推定出生時発生率は、100,000人あたり2.53であり、世界的な発生率よりも高いです。
- GLDC遺伝子変異、特にc.1166C>T(p.A389V)変異が、研究対象集団で広く見られました。
結論:
- 中央およびアパラチアケンタッキー州では、世界的な推定値と比較してNKHの発生率が高いです。
- 特定のGLDC変異(p.A389V)が地域的に濃縮されていることが示されています。
- これらの所見は、NKHに対する臨床医の認識向上、標的を絞った研究、および地域スクリーニングと管理プロトコルの情報提供の必要性を強調しています。
関連する概念動画
Inborn Errors of Metabolism
691
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
691
Hypoglycemia and Glucagon
822
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
822
Overview of Protein Metabolism
3.6K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
3.6K
Glucose Transporters
27.1K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.1K
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K

